{
    "nctId": "NCT02688803",
    "briefTitle": "Multicentre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Three Standard of Care Regimens for The Treatment of Triple-Negative Breast Cancer in the Neoadjuvant/Adjuvant Setting (REaCT-TNBC)",
    "officialTitle": "Multicentre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Three Standard of Care Regimens for The Treatment of Triple-Negative Breast Cancer in the Neoadjuvant/Adjuvant Setting (REaCT-TNBC) OTT 15-04",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "HEALTH_SERVICES_RESEARCH",
    "enrollmentCount": 2,
    "primaryOutcomeMeasure": "Percentage of patients who receive chemotherapy in the neoadjuvant/adjuvant setting for TNBC",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically confirmed primary TNBC breast cancer\n* Planned for chemotherapy\n* \u226518 years of age\n* Able to provide verbal consent\n* Willing to complete a survey\n\nExclusion Criteria:\n\n* Metastatic disease\n* Contraindication to one or more of the chemotherapy agents being evaluated in the study",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}